Related Experiment Video

Updated: Aug 6, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword?

S D Killeen1, J H Wang, E J Andrews

  • 1Department of Academic Surgery, National University of Ireland (NUI)/University College Cork (UCC), Cork University Hospital, Cork, Ireland.

British Journal of Cancer
|August 8, 2006
PubMed

Insights

The toll-like receptor (TLR) system is crucial for immune responses and cancer immunotherapy. However, cancer can hijack TLR pathways, making the system a double-edged sword requiring careful manipulation in cancer treatment.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are ancient pattern recognition receptors vital for immune activation.
  • TLR agonists are established immunoadjuvants in cancer immunotherapy.
  • Emerging evidence links TLR signaling to cancer progression and pathogenesis.

Purpose of the Study:

  • To review the dual role of TLRs in cancer.
  • To explore therapeutic potential and risks of manipulating TLR pathways in oncology.
  • To highlight the need for cautious application of TLR-targeting strategies.

Main Methods:

  • Literature review of clinical and experimental studies on TLRs in cancer.
  • Analysis of TLR signaling pathways in neoplastic processes.
  • Evaluation of immunoadjuvant and pathogenetic roles of TLRs.

Main Results:

  • TLRs are implicated in both anti-cancer immunity and cancer progression.
  • Cancer cells can exploit TLR pathways for survival and advancement.
  • Targeting TLRs presents therapeutic opportunities but carries risks of promoting cancer survival.

Conclusions:

  • The TLR system is a double-edged sword in cancer, offering both therapeutic potential and risks.
  • Careful manipulation of TLR pathways is essential for effective cancer immunotherapy.
  • Further research is needed to safely harness TLRs against neoplastic diseases.

More Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...